Quest Diagnostics Q4 rev $2.74B (-9% YoY); FY EPS beats outlook; 2022 guidance raised

QUEST DIAGNOSTICS INC

2021-FY EPS reported $15.55 revenue$10,788,000,000

Preliminary Q4 2021 revenue ~$2.74B, down 9% from $3.00B in Q4 2020.
Q4 reported diluted EPS $3.12; adjusted diluted EPS $3.33 (vs $4.48 adjusted in Q4 2020).
Full year 2021 revenue ~$10.79B (+14% YoY); adjusted diluted EPS $14.24 exceeded prior outlook.
COVID-19 testing demand higher than expected; Q4 included 7.9M molecular tests and 0.7M serology tests.
2022 guidance raised: now expects adjusted diluted EPS above $8.00 (prior was near upper end of $7.40-$8.00).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.